Abstract:Introduction: Generalized pustular psoriasis (GPP) is a rare and severe psoriasis subtype characterized by the rapid onset of coalescing sterile pustules over broad body areas and systemic inflammation. Data on its clinical course and outcomes in Taiwan are limited. We evaluated the clinical profile and outcomes of patients with GPP flares in Taiwan. Methods: This retrospective analysis included adult patients with moderate-to-severe GPP flares occurring in January 2008-December 2021. Data were extracted from medical charts and electronic health records in the Chang Gung Research Database. Statistical analyses were performed using SAS for Windows (version 9.4). Multivariate Poisson regression models were built to investigate different predictors of GPP flare rate. Results: Thirty-four patients with 81 moderate-to-severe GPP flares were identified. Of the 14 patients undergoing genetic analysis, 10 (71.4%) had an IL36RN mutation. Patients' mean age at the index GPP flare was 47.1 ± 16.5 years; 58.0% of the flares were severe, while 42.0% were moderate. Overall, 96.3% of GPP flares were treated with at least one systemic therapy, acitretin being the most prescribed (85.2%), followed by cyclosporine (45.7%) and methotrexate (18.5%). After treatment, the proportion of flares responding positively increased from 0% on day 2 to 6.2% by week 12. Patients were newly diagnosed with psoriasis (23.5%), hypertension (20.6%), diabetes mellitus (14.7%), psoriatic arthritis (2.9%), malignant tumor (8.8%), and depression/anxiety (2.9%) after enrollment. Complications occurring within 12 weeks of GPP flares included arthritis (25.9% of the flares), skin infection (8.6%), and other infections (2.5%). No fatalities were reported. In the multivariate model, former smokers, patients with hepatic disease, and patients with psoriatic arthritis had an increased GPP rate ratio (RR) of 13.33 (95% confidence interval, CI, 2.87-61.78), 14.08 (95% CI 3.04-65.29), and 34.84 (95% CI 4.77- 254.42), respectively. Contrarily, obese and rheumatoid arthritis patients had a lower GPP rate ratio of 0.21 (95% CI 0.08-0.54) and 0.07 (95% CI 0.006-0.78), respectively. Conclusions: Our findings highlight the complexity of GPP flare presentations and the need for individualized, patient-centered management approaches and continued research to improve affected individuals' care and outcomes.

Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP

Asia‐Pacific consensus recommendations on the management of generalized pustular psoriasis

The Prevalence and Disease Characteristics of Generalized Pustular Psoriasis

Expert Consensus on the Treat-to-target Strategy for Psoriasis with Biological Agents in China

Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search

Treatment Options and Goals for Patients with Generalized Pustular Psoriasis

Considerations for defining and diagnosing generalized pustular psoriasis

Regional differences in the prevalence of generalized pustular psoriasis in Japan

Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares

Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

A review of disease burden and clinical management for generalized pustular psoriasis in China

Generalized Pustular Psoriasis and Systemic Organ Dysfunctions

An update on genetic basis of generalized pustular psoriasis (Review)

Comprehensive Treatment Approaches in a Unique Case of Generalized Pustular Psoriasis

Clinical characteristics and health-care resource utilization in patients with generalized pustular psoriasis using real-world evidence from the Japanese Medical Data Center database

Clinical Disease Measures in Generalized Pustular Psoriasis

Clinical Characteristics and Disease Burden of Patients with Moderate-to-Severe Generalized Pustular Psoriasis Flares in Taiwan

Asian Consensus on Assessment and Management of Mild to Moderate Plaque Psoriasis with Topical Therapy.

The update of treatment strategies in pediatrics with generalized pustular psoriasis in China

Indian expert Delphi consensus on the diagnosis and management of flares of generalised pustular psoriasis

Treatment patterns and drug survival for generalized pustular psoriasis: A patient journey study using a Japanese claims database